Rapid Detection of high-level oncogene amplifications in ultrasonic surgical aspirations of brain tumors

Diagnostic Pathology

Volumn 7, Issue 1, 2012, Pages

  Truong, Long N ^a   Patil, Shashikant ^b   Martin, Sherry S ^c   LeBlanc, Jay F ^d   Nanda, Anil ^e   Nordberg, Mary L ^e,f,g   Beckner, Marie E ^e  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Delta Pathology Group   (United States)

^d LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^e Louisiana State University School of Medicine Shreveport   (United States)

^f LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^g Delta Pathology Molecular Diagnostics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; FIXATIVE; FORMALDEHYDE; PARAFFIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BRAIN TUMOR; CENTRIFUGATION; COMPARATIVE STUDY; EPENDYMOMA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENETICS; GLIOBLASTOMA; HUMAN; LUNG TUMOR; MALE; METASTASIS; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; NEEDLE BIOPSY; ONCOGENE; PATHOLOGY; PREDICTIVE VALUE; REPRODUCIBILITY; TIME; TISSUE FIXATION; ULTRASOUND SURGERY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; BRAIN NEOPLASMS; CENTRIFUGATION; EPENDYMOMA; FEMALE; FIXATIVES; FORMALDEHYDE; GENE AMPLIFICATION; GLIOBLASTOMA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; ONCOGENES; PARAFFIN EMBEDDING; PREDICTIVE VALUE OF TESTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; REPRODUCIBILITY OF RESULTS; TIME FACTORS; TISSUE FIXATION; TUMOR MARKERS, BIOLOGICAL; ULTRASONIC SURGICAL PROCEDURES;

EID: 84861968435     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-7-66     Document Type: Article

References (24)

1. Flamm ES, Ransohoff J, Wuchinich D, Broadwin B. Preliminary experience with ultrasonic aspiration in neurosurgery. Neurosurgery 1978, 2:240-45. 10.1227/00006123-197805000-00010, 732976.
2. Beckner ME, Jane EP, Jankowitz B, Agostino NR, Walter KA, Hamilton RL, Pollack IF, Hamilton RL. Tumor cells from ultrasonic aspirations of glioblastomas migrate and form spheres with radial outgrowth. Cancer Lett 2007, 255:135-44. 10.1016/j.canlet.2007.04.005, 2000342, 17543444.
3. Finley JL, Silverman JF, Dickens MA. Immunocytochemical evaluation of central nervous system tumors obtained by the Cavitron ultrasonic surgical aspirator. Diagn Cytopathol 1990, 6:308-12. 10.1002/dc.2840060504, 1705495.
4. Oakes WJ, Friedman HS, Bigner SH, Bullock NH, Bigner DD. Successful laboratory growth and analysis of CUSA-obtained medulloblastoma samples, Technical note. J Neurosurg 1990, 72:821-23. 10.3171/jns.1990.72.5.0821, 2324807.
5. Beckner ME, Sampath R, Flowers AB, Katira K, D'Souza D, Patil S, Patel RB, Nordberg ML, Nanda A. Low level amplification of oncogenes correlates inversely with age for patients with non-typical meningiomas. World Neurosurgery 2011 Available online Nov 7..
6. Parsons DW, Jones S, Zhang X, Lin C-HJ, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008, 321:1807-12. 10.1126/science.1164382, 2820389, 18772396.
7. Albertson DG. Gene amplification in cancer. Trends Genet 2006, 2006(22):447-55.
8. Hastings PJ. Adaptive amplification. Crit Rev Biochem Mol Biol 2007, 42:271-83. 10.1080/10409230701507757, 17687669.
9. Gulati S, Ytterhus B, Granli US, Gulati M, Lydersen S, Torp SH. Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas. Diag Pathol 2010, 5:18.
10. Lopez-Gines C, Gil-Benso R, Ferrer-Luna R, Benito R, Serna E, Gonzalez-Darder J, Quilis V, Monleon D, Celda B, Cerdá-Nicolas M. New pattern of EGFR amplification in glioblastoma and the relationship of gene copy number with gene expression profile. Mod Pathol 2010, 23:856-65. 10.1038/modpathol.2010.62, 20305620.
11. Jeuken J, Sijben A, Alenda C, Rijntjes J, Dekkers M, Boots-Sprenger S, McLendon R, Wesseling P. Robust detection of EGFR copy number changes and EGFR variant III: Technical aspects and relevance for glioma diagnostics. Brain Pathol 2009, 19:661-71. 10.1111/j.1750-3639.2009.00320.x, 19744038.
12. Mellinghoff IK, Wang MY, Vivanco I, Haas-Kogan DA, Zhu S, Dia EQ, Lu KV, Yoshimoto K, Huang JH, Chute DJ. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. New Eng J Med 2005, 353:2012-24. 10.1056/NEJMoa051918, 16282176.
13. Prados MD, Lamborn KR, Chang S, Burton E, Butowski N, Malec M, Kapadia A, Rabbitt J, Page MS, Fedoroff A, et al. Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma. Neuro-Oncol 2006, 8:67-78. 10.1215/S1522851705000451, 1871925, 16443950.
14. Prados MD, Chang SM, Butowski N, DeBoer R, Parvataneni R, Carliner H, Kabuubi P, Ayers-Ringler J, Rabbitt J, Page M, et al. Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma. J Clin Oncol 2009, 27:579-84. 2645859, 19075262.
15. Raizer JJ, Abrey LE, Lassman AB, Chang SM, Lamborn KR, Kuhn JG, Yung WK, Gilbert MR, Aldape KA, Wen PY, et al. North American Brain Tumor Consortium: A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy. Neuro-Oncol 2010, 12:95-103. 10.1093/neuonc/nop015, 2940554, 20150372.
16. Rao SK, Edwards J, Joshi AD, Siu I-M, Riggins GJ. A survey of glioblastoma genomic amplifications and deletions. J Neurooncol 2010, 96:169-79. 10.1007/s11060-009-9959-4, 19609742.
17. Ruano Y, Mollejo M, Ribalta T, Fiano C, Camacho FI, Gomez E, de Lope AR, Hernández-Moneo JL, Martínez P, Meléndez B. Identification of novel candidate target genes in amplicons of glioblastoma multiforme tumors detected by expression and CGH microarray profiling. Mol Cancer 2006, 5:39. 1592108, 17002787.
18. Benito R, Gil-Benso R, Quilis V, Perez M, Gregori-Romero M, Roldan P, Gonzalez-Darder J, Cerdá-Nicolas M, Lopez-Gines C. Primary glioblastomas with and without EGFR amplification: Relationship to genetic alterations and clinicopathological features. Neuropathology 2010, 30:392-400.
19. Fischer U, Leidinger P, Keller A, Folarin A, Ketter R, Graf N, Lenhof HP, Meese E. Amplicons on chromosome 12q13-21 in glioblastoma recurrences. Int J Cancer 2010, 126:2594-602.
20. Maas RM, Reus K, Diesel B, Steudel WI, Feiden W, Fischer U, Meese E. Amplification and expression of splice variants of the gene encoding the P450 cytochrome 25-hydroxyvitamin D(3) 1, alpha-hydroxylase (CYP27B1) in human malignant glioma. Clin Cancer Res 2001, 7:868-75.
21. Agarwal R, Gonzalez-Angulo AM, Myhre S, Carey M, Lee JS, Overgaard J, Lenhof HP, Meese E, Alsner J, Stemke-Hale K, et al. Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer. Clin Cancer Res 2009, 15:3654-62. 10.1158/1078-0432.CCR-08-3293, 2887710, 19470724.
22. Etemadmoghadam D. deFazio A, Beroukhim R, Mermel C, George J, Getz G, Tothill R, Okamoto A, Raeder MB, Harnett P, et al: AOCS Study Group: Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas. Clin Cancer Res 2009, 15:1417-27. 10.1158/1078-0432.CCR-08-1564, 2670486, 19193619.
23. Moelans CB, de Weger RA, van Blokland MTM, Ezendam C, Elshof S, Tilanus MG, van Diest PJ. Her- 2/neu amplification testing in breast cancer by multiplex ligation-dependent probe amplification in comparison with immunohistochemistry and in situ hybridization. Cellular Oncol 2009, 31:1-10.
24. Moelans CB, de Weger RA, van Blokland MT, van der Wall E, van Diest PJ. Simultaneous detection of TOP2A and HER2 gene amplification by multiplex ligation-dependent probe amplification in breast cancer. Mod Pathol 2010, 23:62-70. 10.1038/modpathol.2009.136, 19767729.